United States· US:67877-172_b4d4d6f0-2b78-4882-add2-7c6218270b7f

Olanzapine

A olanzapine product containing olanzapine, registered in United States by Ascend Laboratories, LLC. The same ATC class is registered in 18 of our 19 countries.

ATC N05AH03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOlanzapineATCN05AH03REGISTER NO.US:67877-172_b4d4d6f0…PACKS LISTED12CHECKEDSeptember 27, 2026

Where it is registered

Olanzapine is registered in 18 of 19 countries.

Countries holding a registration under ATC N05AH03 (olanzapine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose

Olanzapine · ATC N05AH03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of olanzapine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.17 in United States to $3.34 in Switzerland — a ×19 gap.

  • United States: $0.17 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Olanzapine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.34
  • IT Italy$1.59
  • FR France$0.63
  • US United States$0.17 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OLANZAPINE
Manufacturer
Ascend Laboratories, LLC
Country
United States (US)
ATC code
N05AH03
ATC class
Olanzapine
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 12

  • ndc11
    67877-172-10
  • ndc11
    67877-172-30
  • ndc11
    67877-172-32
  • ndc11
    67877-172-35
  • ndc11
    67877-172-85
  • ndc11
    67877-172-01
  • ndc11
    6787717201
    100 TABLET in 1 BOTTLE (67877-172-01)
  • ndc11
    6787717210
    1000 TABLET in 1 BOTTLE (67877-172-10)
  • ndc11
    6787717230
    30 TABLET in 1 BOTTLE (67877-172-30)
  • ndc11
    6787717232
    7 TABLET in 1 BOTTLE (67877-172-32)
  • ndc11
    6787717235
    10 BLISTER PACK in 1 CARTON (67877-172-35) / 10 TABLET in 1 BLISTER PACK (67877-172-33)
  • ndc11
    6787717285
    3 BLISTER PACK in 1 CARTON (67877-172-85) / 10 TABLET in 1 BLISTER PACK (67877-172-33)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

481 interactions on record for olanzapine.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Olanzapine · interactions on record

481 records

  • 14 severe
  • 292 moderate
  • 3 minor
  • 137 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe

35 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Olanzapine in 18 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olanzapine products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Aedon, Olanzapin +pharma
  • Belgium · Olanzapine, Olanzapine Ab
  • Bulgaria · Oлфрекс, Еголанза
  • Cyprus · Bloonis, Lapozan
  • Czechia · Egolanza, Nykob
  • Germany · Olanzapin 1 A Pharma, Olanzapin Abz
  • Denmark · Farpenta, Kynapine Odt
  • Estonia · Farpenta, Olanzapin Actavis
  • Spain · Arenbil, Arenbil Flas
  • Finland · Olanzapin Orion, Olanzapin Ratiopharm
  • France · Olanzapine Accord, Olanzapine Arrow
  • United Kingdom (Northern Ireland) · Olanzapine Accord, Olanzapine Bristol Laboratories
  • Greece · Bloonis, Caprilon Od
  • Croatia · Olandix, Olanzalux
  • Hungary · Egolanza, Olpinat
  • Ireland · Olanzapine Accord, Olanzapine Accord Healthcare Ireland
  • Iceland · Olanzapin Actavis, Olanzapine Teva
  • Italy · Farpenta, Lazapir
  • Liechtenstein · Olanzapine Teva, Olanzapine Viatris
  • Lithuania · Olanzapin Actavis, Olanzapine Accord
  • Luxembourg · Olanzapine Eg, Olanzapine Instant Eg
  • Latvia · Olanzapine Accord
  • Malta · Olancer, Olanzapine Aurobindo
  • Netherlands · Olanzapine Accord, Olanzapine Aurobindo
  • Norway · Olanzapine Accord, Olanzapine Teva
  • Poland · Egolanza, Olanzapina Viatris
  • Portugal · Olanzapina Alter, Olanzapina Aurobindo
  • Romania · Olanzapină Arena, Olanzapina Aurobindo
  • Sweden · Olanzapin Actavis, Olanzapin Sandoz
  • Slovenia · Zolrix
  • Slovakia · Olanzapin Actavis, Olanzapin Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af4cc960-ba3c-48b6-89e9-8c4600b6e8f0
GET /v1/drugs/af4cc960-ba3c-48b6-89e9-8c4600b6e8f0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2.5",
  "substance": "OLANZAPINE",
  "productndc": "67877-172",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA202295",
  "marketing_category": "ANDA"
}

See everything about olanzapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.